Key Initiatives Victorian Biotechnology Strategy

Slides:

Advertisements

Similar presentations

What is Biotechnology Biotechnology is a broad term that applies to all practical uses of living organisms -- anything from microorganisms used in the.

Advertisements

1 CTI Life Sciences Fund Introduction January 2008.

MEDICAL BIOTECHNOLOGY IN VIETNAM Ass. Prof. Nguyen Van Tuong, MD., Ph.D. Hanoi Medical University.

David M. Pollock Medical College of Georgia Discovery-Academia.

CONTRACT RESEARCH SERVICES 1537 NW 65th Avenue Plantation, FL USA Phone: (954) Fax: (954)

Develop and Utilize Human Potential 1. Qatar Research Institutes.

Eli Lilly and Company – Tailored Therapeutics and Diagnostics © Eli Lilly and Company 2012 The views and opinions expressed herein and/or during the accompanying.

1 February 15, 2006 Global Forum: Building Science, Technology and Innovation Capacity for Sustainable Growth and Poverty Reduction Prof. Bonnie Patterson.

25 November Prof Nigel Laing WA Institute for Medical Research (WAIMR)

Bio-technology - The Readiness of Hong Kong Opening Speech by Dr. K. S. Lo Chairman, GEM Listing Committee, Hong Kong Exchanges and Clearing Ltd. 21 October.

NCI Designation: Expanding Science and Promoting Health in the Region Name Title, Company Date.

Influencing Change in Research, Treatment Protocols, and New Drug Development.

EDC PHARMA SERVICES Capacity. Expertise. Solutions. Technology.

29-1 The Technological Revolution. ENIAC Electronic Numerical Integrator and Computer World’s first electronic digital computer Weighed 30 tons,

Genomics Commercialization Glen Schuler Managing Director, Industry Liaison Office University of Saskatchewan.

Health and Medical Science Nick Besley Manager, Marketing and Communications, Science, Engineering and Health.

Yale Pharmaceutical & Biotechnology Society EQUITYRESEARCHCLUB.

EoI assesment and presentation NCP 24 October 2002 Confronting the major communicable diseases linked to poverty Health Directorate F3 unit: Poverty related.

Understanding Neurons and the Circuitry of the Brain Jonathan H. Manton The University of Melbourne November 2008.

Workforce Development for the Biotech Industry. Workforce Development National Level State Level Corporate Level Current Programs Future Requirements.

N O R T H C A R O L I N A B I O T E C H N O L O G Y C E N T E R North Carolina – Leading Global Hub for Agricultural Biotechnology NCBiotech - AgBiotech.

1 ICON plc Investor Update March Certain statements contained herein including, without limitation, statements containing.

CRICOS: 00116K Biomedical Engineer: Design products and procedures that solve medical problems. These include artificial organs, prostheses, instrumentation,

Jennifer H. Moore, Ph.D. Executive Director Southeast Region Technology Transfer Directors Meeting July 30, 2010.

Biotech Clusters in British Columbia. To be the catalyst for a life sciences cluster of genomics-related research institutions and companies working together.

Innovation: Victoria’s Future Overview of new ICT & Technology Programs Ballarat, 21 October 2008.

Nathan Tinker Executive Director New York Biotechnology Association New York BizBio 2009 Fighting for a Healthy Biotech Industry.

Dr Stewart Hay, CEO | | (03) www.therapeuticinnovation.com.au.

Qatar Foundation for Education, Science and Community Development is a private, chartered, non-profit organization in the state of Qatar, Founded in 1995.

1 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference 2008 Dr. John Climax Executive Chairman.

The State of the Massachusetts Life Science Industry - The Year in Review - June 2, 2011 MALSI | MA Life Sciences Innovation Day.

September 13, 2007SGH&M2B International&Training Workshop What does the European Technology Platform “Innovative Medicines initiative” offer? Vitalijs.

Global Recognition of the Indian Biotech Sector - The Road Ahead Sept 26,2003 Hyderabad.

Nasdaq - QCOR.  Healthcare  Biotechnology  Market Cap Billion  Aggressive Growth Stock  Anaheim, California  557 Employees.

FOR OFFICIAL USE ONLY Victorian Science and Innovation Directions Dr Amanda Caples Deputy Secretary, Sector Development and Programs Department of Economic.

Figure 1.1. Industry Value Chain Problem to be solved Technology innovation Basic research Applied research Pilot phase (Prod dev) Application phase (Production)

“Australia is #1 site to conduct clinical trials” “Australia is #1 site to conduct clinical trials” Summary of Economist Intelligence Unit Report: Benchmarking.

Unprecedented Growth & Future Job Opportunity BIOTECHNOLOGY Dr. Sanjiv Kumar Maheshwari Professor and Dean, IFTM University, Moradabad.

Browse more Reports on Clinical Trials at

NOBEL PRIZE FOR MEDICINE Prof Barry Marshall -Prof Robin Warren AUSTRALIAN OF THE YEAR Prof Fiona Wood Prof Fiona Stanley HEALTH REFORM.

NSW Government Agencies Supporting Clinical Trials Strategic Planning, Policy Advice & Funding for Medical Research Economic Development & Support for.

DVP II Life sciences & health 4-14 May DVP Health & life sciences Objectives: Participants: 8 experts in healthcare & life sciences from different.

httpwww.youtube.com/watch?v=DhxD6sVQEYc:// The Drug Discovery Process.

Driving Innovation V Driving Innovation V Invitation to further collaboration Dr Anne Miller Environmental Sustainability KTN.

© 2016 Global Market Insights, Inc. USA. All Rights Reserved U.S. Digital Genome Market share accounted for over 80% of the North American revenue in 2015.

Developing and Broadening Specialists in Research & Development

Success Stories of Globalization in Korean Pharma

A Survey of the Swedish Biotech pipeline

Toronto region is the only growing metro region in north America

Lithuania: Biotechnology

Bridging Biomedical Research

Today’s Drug Discovery Process “How Do We Discover Drugs”

FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health

Dr. Siegfried Bialojan Background Skills Professional experience

Appendix III: Scope of Service of CUHK Service Units

South Australian Life Science Initiatives

Strategic Benchmarking Research & Analysis

Gestora brasileiro focada exclusivamente na área da saúde.

Apollo Research & Innovations (ARI)

Medical biotechnology is our topic.

2018 Tax Team Benchmarking Survey

Medical Technology Industry Sector Blueprint

Tamar Raz, PHD.

Clinical and Translational Science Awards Program

Australia's National Information Infrastructure for Research Markus Buchhorn Director, ICT Environments, The Australian National University (and APAC,

FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health

Pharmaceuticals Industry

30/30 HORIZONS IN HEALTHCARE RESEARCH NHMRC Clinical Trials Centre

Facts about the Australia Education Market

Presentation transcript:

Key Initiatives Victorian Biotechnology Strategy 2004-2007 Aim to be in top 5 biotech cities by 2010 Over $500m committed to biotechnology initiatives Australian Synchrotron Kangaroo Genome Sequencing Project Australian Stem Cell Centre Victorian Partnership for Advanced Computing Centre for Pre-Clinical Drug Candidate Optimisation Nucleus Network National Neurosciences Facility Nanotechnology Victoria Bio21 Institute Graham Clarke Institute (formerly Bionic Ear Institute) RMIT Drug Discovery Technologies (RDDT) VESKI Bringing Australian expatriate scientists back to Australia

Drug Development Capabilities Centre for Drug Candidate Optimisation STC - GxP Scale-Up MFG R & D Pre Clinical Phase I Phase II Phase III Biopharmaceutical Formulation and Finishing Sciences Centre AMREP

Facts & Figures Over 100 core biotech companies in Melbourne 43 stock market listed companies : Market cap >$16billion 6,100 people employed by Vic biotech companies, 30% emerging biotech companies, 70% established pharma $280m raised in last 12 months by Victorian Biotechs In excess of 500 clinical trials conducted across Melbourne institutions annually More than 20 specialist Medical Research institutes Home of discoveries such as Colony Stimulating Factors – (GM-CSF), Neuraminidase inhibitors – (Relenza)

Contacts Nucleus Network www.nucleusnetwork.com.au Andrew Giddy (a.giddy@nucleusnetwork.com.au) Lisa Nelson (l.nelson@centreforclinicalstudies.com.au) Maria Chiam (m.chiam@nucleusnetwork.com.au) Maria is located in San Francisco PH: 415- 544 0958 Invest Victoria www.invest.vic.gov.au David Brown (sanfrancisco@invest.vic.gov.au) BioMelbourne Network www.biomelbourne.org Tim Murphy (tmurphy@biomelbourne.org) Biotechnology Victoria www.biotechnology.vic.gov.au Amanda Caples (amanda.caples@iird.vic.gov.au)